22 hrs ago | Hartford Courant
Greater New Britain: Southington Teen Claims Adversity Tightened Bonds Of Love
People Submitted by Karen E. Butler on 2009-07-02.   Southington residents Jennifer Castonguay and her daughter Jessica Castonguay at the June 8 reception honoring the 2009 Hayley's Hope & Michaela's Miracle MS Scholarship recipients.
Important Modulator Of Immune Cell Entry Into The Brain Discovered
Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells.
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement...
Biogen Idec and Acorda Therapeutics Announce Collaboration Agreement to Develop and Commercialize MS Therapy Fampridine-SR in Markets Outside the U.S. Acorda to Continue to Develop and Commercialize Fampridine-SR in the U.S. Upfront Payment of $110 Million; Potential Deal Value Over $500 Million Acorda to Host Conference Call at 8:30 a.m. Eastern ...
New clue into how brain stem cells develop into cells which repair damaged tissue
The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco and University of Cambridge and was published today in the journal Genes and Development.
UCB Group and Biogen Idec, Inc. (Massachusetts) Discontinue Phase II Clinical Trial of CDP323
UCB and Biogen Idec announced today the discontinuation of the Phase II clinical trial of CDP323 for the treatment of relapsing multiple sclerosis .
MS patient should find support elsewhe...
DEAR ANNIE: I am 49, the eldest of four siblings and have been suffering with multiple sclerosis for years.
MP Maclean set to stand down David Maclean, Conservative MP for...
David Maclean, Conservative MP for Penrith and the Border for 26 years, is to stand down at the next election.
Modern multiple sclerosis treatment - what is approved, what is on the horizon.
NEW dalia NEW Abstract In the mid-1990s, the implementation of the immunomodulatory drugs interferon-beta and glatiramer acetate offered the first evidence-based treatment option for multiple sclerosis .
10th Tysabri PML case sinks Biogen shares
The Biogen Idec sign welcomes visitors to the company's RTP operations. Shares of Biogen Idec sunk Monday after the biotechnology giant confirmed that another patient taking the multiple sclerosis drug Tysabri has been diagnosed with a potentially fatal brain infection called progressive multifocal leukoencephalopathy, or PML.
Science, Industry and Business
New Control System of the Body Discovered - Important Modulator of Immune Cell Entry into the Brain
Researchers in Berlin, Germany have ameliorated inflammation of the brain in mice caused by immune cells.
Novartis in talks to buy much of Elan: report
Swiss drugmaker Novartis is in talks to buy parts of Irish peer Elan , including its flagship multiple sclerosis products and its Alzheimer's disease pipeline, the Sunday Times said.
Institute of Food Technologists
Vitamin D Sufficiency Challenges and Opportunities for the Food Industry
Scientific evidence shows vitamin D may go beyond its traditionally known role in maintaining bone integrity, according to new research presented at the Institute of Food Technologists Annual Meeting and Food Expo earlier this month.
Figuring Out Who Will Benefit Most From A New Therapy For Multiple Sclerosis
In a recent phase II clinical trial, the drug alemtuzumab was found to be a highly effective treatment for individuals with early relapsing-remitting multiple sclerosis.
Rotary Donation Will Aid Research Into MS
THE Rotary Club of Kirriemuir has presented the Multiple Sclerosis Society of Scotland with a cheque for A 8,000, being the net proceeds from its Thrums Charity Dinner in April.
NYU study may find better treatments for MS
David Rice Jr. had not even reached his 40th birthday when he found out he had multiple sclerosis.
Advanced nerve cell system could help cure diabetic neuropathy, related diseases
Multiple sclerosis, diabetic neuropathy, and other conditions caused by a loss of myelin insulation around nerves can be debilitating and even deadly, but adequate treatments do not yet exist.
Court told man paid 25k for 'rubbish' data
A MAN who lost his investment in an alleged 700,000 business scam has told a court of his experience.
Biogen Idec Begins Phase III Enrollment for RMS Drug
Biogen Idec has enrolled the first patient in a Phase III, randomized, double-blind, placebo-controlled trial designed to evaluate the efficacy and safety of PEGylated interferon beta-1a in patients with relapsing multiple sclerosis .
Researchers Piece Together More Of The Multiple Sclerosis Genetic Code
Main Category: Multiple Sclerosis Also Included In: Genetics Article Date: 17 Jun 2009 - 0:00 PDT Australian and New Zealand scientists are a step closer to unravelling what causes multiple sclerosis.
Protecting Your Job While Coping With a Chronic Illness
Published: Saturday, June 20, 2009 at 5:13 a.m. Last Modified: Saturday, June 20, 2009 at 5:13 a.m. IT started with an odd sensation in her right hand and a feeling of exhaustion so profound she could hardly get through an hour of work, let alone a full day.